# BCAX (Bicara Therapeutics Inc.) - SEC EDGAR Financial Statements

> Bicara Therapeutics Inc. reported $460.6M in total assets and a net loss of $220.3M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BCAX
- Markdown: https://convexityos.com/fundamentals/BCAX.md
- SEC CIK: 0002023658
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:33 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002023658&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$237.0M | Operating profit |
| Net Income | FY 2025 | -$220.3M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$3.22 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$162.8M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $442.3M | Total debt: $880K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Research & Development | -- | $63.60M | $30.60M |
| Total Operating Expenses | $155.6M | $82.39M | $39.89M |
| **Operating Income** | -$155.6M | -$82.39M | -$39.89M |
| **EBITDA** | -$155.5M | -$82.33M | -$39.87M |
| Interest Income | $17.87M | $14.58M | $1.31M |
| Income Before Tax | -$137.7M | -$67.81M | -$51.98M |
| Income Tax Expense | $217K | $187K | $5.0K |
| **Net Income** | -$137.9M | -$68.00M | -$51.98M |
| Basic EPS | -$2.52 | -$4.05 | -$89.61 |
| **Diluted EPS** | -$2.52 | -$4.05 | -$89.61 |
| Basic Shares Outstanding | 54.68B | 16.81B | 580.1M |
| Diluted Shares Outstanding | 54.68B | 16.81B | 580.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | -- | -- | -- | -- | $33.00M | $24.80M | $34.30M | $19.90M |
| Total Operating Expenses | $75.71M | $59.95M | $60.24M | $41.12M | $40.68M | $32.02M | $41.79M | $26.64M |
| **Operating Income** | -$75.71M | -$59.95M | -$60.24M | -$41.12M | -$40.68M | -$32.02M | -$41.79M | -$26.64M |
| **EBITDA** | -$75.65M | -$59.91M | -$60.20M | -$41.08M | -$40.65M | -$32.00M | -$41.77M | -$26.62M |
| Interest Income | $4.52M | $4.58M | $4.08M | $3.79M | $4.39M | $4.68M | $5.01M | $5.87M |
| Income Before Tax | -$71.19M | -$55.38M | -$56.16M | -$37.33M | -$36.29M | -$27.34M | -$36.77M | -$20.77M |
| Income Tax Expense | $54K | $61K | $52K | $53K | $40K | $52K | $72K | $186K |
| **Net Income** | -$71.25M | -$55.44M | -$56.21M | -$37.39M | -$36.33M | -$27.39M | -$36.85M | -$20.96M |
| Basic EPS | -$1.04 | -$0.82 | -$0.93 | -- | -$0.67 | -$0.50 | -$0.68 | -- |
| **Diluted EPS** | -$1.04 | -$0.82 | -$0.93 | -- | -$0.67 | -$0.50 | -$0.68 | -- |
| Basic Shares Outstanding | 68.4M | 67.9M | 60.7M | -- | 54.6M | 54.5M | 54.5M | -- |
| Diluted Shares Outstanding | 68.4M | 67.9M | 60.7M | -- | 54.6M | 54.5M | 54.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $96.69M | $489.7M | $230.4M |
| Short-Term Investments | $318.1M | $0 | -- |
| **Cash & Short-Term Investments** | $414.8M | $489.7M | $230.4M |
| **Total Current Assets** | $422.1M | $502.5M | $231.1M |
| Property, Plant & Equipment, Net | $330K | $155K | $202K |
| Long-Term Investments | -- | $0 | -- |
| Other Non-Current Assets | $6.91M | $6.62M | $2.09M |
| **Total Non-Current Assets** | $8.94M | $7.46M | $2.91M |
| **Total Assets** | $431.0M | $510.0M | $234.0M |
| **Total Current Liabilities** | $28.95M | $17.99M | $15.09M |
| Other Non-Current Liabilities | -- | $0 | $17K |
| **Total Non-Current Liabilities** | $593K | $131K | $389K |
| **Total Liabilities** | $29.54M | $18.12M | $15.47M |
| **Total Debt (incl. Leases)** | $1.71M | $738K | $657K |
| Common Stock | $7.0K | $7.0K | $2.0K |
| Retained Earnings | -$359.0M | -$221.0M | -$153.0M |
| Accumulated Other Comp. Income | $243K | $0 | -- |
| **Total Stockholders' Equity** | $401.5M | $491.9M | -$148.8M |
| Total Equity | $401.5M | $491.9M | -$148.8M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $82.02M | $96.60M | $323.5M | $96.69M | $171.7M | $436.6M | $462.1M | $489.7M |
| Short-Term Investments | $360.3M | $400.7M | $216.3M | $318.1M | $118.5M | -- | -- | $0 |
| **Cash & Short-Term Investments** | $442.3M | $497.3M | $539.8M | $414.8M | $290.2M | $436.6M | $462.1M | $489.7M |
| **Total Current Assets** | $451.4M | $503.8M | $544.9M | $422.1M | $297.4M | $444.4M | $470.8M | $502.5M |
| Property, Plant & Equipment, Net | $965K | $362K | $346K | $330K | $135K | $117K | $136K | $155K |
| Long-Term Investments | -- | -- | -- | -- | $117.4M | -- | -- | $0 |
| Other Non-Current Assets | $7.54M | $6.91M | $6.91M | $6.91M | $7.79M | $6.84M | $6.63M | $6.62M |
| **Total Non-Current Assets** | $9.23M | $8.42M | $8.68M | $8.94M | $127.3M | $9.20M | $7.32M | $7.46M |
| **Total Assets** | $460.6M | $512.2M | $553.6M | $431.0M | $424.7M | $453.6M | $478.1M | $510.0M |
| **Total Current Liabilities** | $51.23M | $43.48M | $39.34M | $28.95M | $21.03M | $17.23M | $19.12M | $17.99M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $0 | $0 | $301K | $593K | $880K | $1.16M | $0 | $131K |
| **Total Liabilities** | $51.23M | $43.48M | $39.64M | $29.54M | $21.91M | $18.39M | $19.12M | $18.12M |
| **Total Debt (incl. Leases)** | $880K | $1.16M | $1.44M | $1.71M | $1.98M | $2.24M | $591K | $738K |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained Earnings | -$541.9M | -$470.6M | -$415.2M | -$359.0M | -$321.6M | -$285.2M | -$257.9M | -$221.0M |
| Accumulated Other Comp. Income | -$1.87M | -$567K | -$243K | $243K | -$136K | -- | -- | $0 |
| **Total Stockholders' Equity** | $409.4M | $468.8M | $514.0M | $401.5M | $402.8M | $435.2M | $459.0M | $491.9M |
| Total Equity | $409.4M | $468.8M | $514.0M | $401.5M | $402.8M | $435.2M | $459.0M | $491.9M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$137.9M | -$68.00M | -$51.98M |
| Depreciation & Amortization | $105K | $56K | $19K |
| Stock-Based Compensation | $15.01M | $7.40M | $1.90M |
| **Operating Cash Flow** | -$106.8M | -$74.75M | -$45.63M |
| Capital Expenditure | -$280K | -$71K | -$586K |
| **Free Cash Flow** | -$107.1M | -$74.82M | -$46.21M |
| Purchases of Investments | -$318.2M | $0 | -- |
| **Investing Cash Flow** | -$318.5M | -$9.0K | -$586K |
| Common Stock Issued | $29.50M | $332.4M | $0 |
| **Financing Cash Flow** | $32.26M | $334.0M | $272.5M |
| **Net Change in Cash** | -$393.0M | $259.3M | $226.3M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$71.25M | -$55.44M | -$56.21M | -$37.39M | -$36.33M | -$27.39M | -$36.85M | -$20.96M |
| Depreciation & Amortization | $60K | $44K | $44K | $43K | $24K | $19K | $19K | $15K |
| Stock-Based Compensation | $9.98M | $8.24M | $5.86M | $4.45M | $3.61M | $3.49M | $3.45M | $3.18M |
| **Operating Cash Flow** | -$56.13M | -$44.21M | -$37.51M | -$23.89M | -$29.25M | -$25.59M | -$28.11M | -$30.03M |
| Capital Expenditure | -$663K | -$60K | -$60K | -$238K | -$42K | $0 | $0 | -$40K |
| **Free Cash Flow** | -$56.79M | -$44.27M | -$37.57M | -$24.12M | -$29.29M | -$25.59M | -$28.11M | -$30.07M |
| Sales & Maturities of Investments | $39.00M | $60.00M | $101.0M | -- | $0 | $0 | $0 | -- |
| **Investing Cash Flow** | $38.34M | -$185.0M | $100.9M | -$82.33M | -$236.1M | $0 | $0 | -$40K |
| Common Stock Issued | $0 | $0 | $161.8M | $29.50M | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | $3.21M | $2.33M | $163.3M | $31.23M | $436K | $135K | $460K | -$975K |
| **Net Change in Cash** | -$14.58M | -$226.9M | $226.8M | -$74.99M | -$264.9M | -$25.46M | -$27.65M | -$31.05M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Return on Equity (ROE) | -34.4% | -13.8% | -- |
| Return on Assets (ROA) | -32.0% | -13.3% | -22.2% |
| Current Ratio | 14.58x | 27.93x | 15.32x |
| Quick Ratio | 14.33x | 27.22x | 15.28x |
| Debt to Equity | 0.00x | 0.00x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -53.8% | -39.5% | -30.6% | -34.4% | -30.2% | -23.6% | -20.1% | -13.8% |
| Return on Assets (ROA) | -47.8% | -36.2% | -28.4% | -32.0% | -28.6% | -22.6% | -19.3% | -13.3% |
| Current Ratio | 8.81x | 11.59x | 13.85x | 14.58x | 14.14x | 25.80x | 24.62x | 27.93x |
| Quick Ratio | 8.63x | 11.44x | 13.72x | 14.33x | 13.80x | 25.34x | 24.17x | 27.22x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
